rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2004-8-17
|
pubmed:abstractText |
Different regimens of agonist and antagonist drugs have been used in opioid withdrawal management, with variable results. We examined whether administering extremely small quantities of opiate antagonists in the presence of opiate agonist drugs reduces withdrawal expression.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0006-3223
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
261-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15312814-Analysis of Variance,
pubmed-meshheading:15312814-Animals,
pubmed-meshheading:15312814-Behavior, Animal,
pubmed-meshheading:15312814-Blotting, Western,
pubmed-meshheading:15312814-Cyclic AMP Response Element-Binding Protein,
pubmed-meshheading:15312814-Cyclic AMP-Dependent Protein Kinases,
pubmed-meshheading:15312814-Drug Administration Schedule,
pubmed-meshheading:15312814-Immunohistochemistry,
pubmed-meshheading:15312814-Locus Coeruleus,
pubmed-meshheading:15312814-Male,
pubmed-meshheading:15312814-Naltrexone,
pubmed-meshheading:15312814-Narcotic Antagonists,
pubmed-meshheading:15312814-Narcotics,
pubmed-meshheading:15312814-Neostriatum,
pubmed-meshheading:15312814-Proto-Oncogene Proteins c-fos,
pubmed-meshheading:15312814-Rats,
pubmed-meshheading:15312814-Rats, Sprague-Dawley,
pubmed-meshheading:15312814-Substance Withdrawal Syndrome
|
pubmed:year |
2004
|
pubmed:articleTitle |
Chronic very low dose naltrexone administration attenuates opioid withdrawal expression.
|
pubmed:affiliation |
Department of Psychiatry and Human Behavior, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|